The proteomics data show lower FOXA1 expression in “pure” DCIS compared with “pure” IDC (P < 0.0001) and increased expression in mixed-type DCIS compared with “pure” DCIS (P = 0.03), suggesting a protective function of FOXA1. Here, FOXA1 is linked to ductal breast carcinoma in situ.